• CRG
  • CRG
  • CRG

Centre for Genomic Regulation (CRG)

CRG

The Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence, created in December 2000. The mission of the CRG is to discover and advance knowledge for the benefit of society, public health and economic prosperity. The CRG believes that the medicine of the future depends on the groundbreaking science of today. This requires an interdisciplinary scientific team focused on understanding the complexity of life from the genome to the cell to a whole organism and its interaction with the environment, offering an integrated view of genetic diseases. CRG is an international institute, with 65% of the PI and 78% of the PhD students being non-nationals.

Excellence and recognition awards

CRG has a successful external funding record:

  • 20 European Research Council (ERC) grants
  • 8 active H2020 projects, 5 of which coordinated by CRG PIs, (17 H2020 projects in total)
  • 29 active FP7 projects, 7 of which coordinated by CRG PIs (74 FP7 projects in total)
Ranking positioning
  • 2015 – 6th  worldwide position in the health sector, according to Q1 – Ratio of Publications indicator in the 2015 Scimago Institutions Ranking report.
Director of the center
Luis Serrano

Luis Serrano

  • He is the director of the CRG and senior group leader of the Systems Biology Program.
  • He completed his PhD on Cell Biology at the Centro de Biología Molecular Severo Ochoa (CBM) in Madrid (Spain).
  • He is an EMBO and RACEFyN member and has received the Marie Curie Excellence Award. He has also received support through the prestigious European Research Comission (ERC) Advanced Grant and support through the prestigious European Research Comission (ERC) Advanced Grant.
  • He has participated as a principal investigator in numerous research projects financed both by the ERC (through the 6th and 7th Framework Programmes) and the Ministry of Science and Innovation of Spain.
  • He is Professor at the Catalan Institution for Research and Advanced Studies (ICREA) and has directed 14 PhD theses.
Renowned researcher
Fátima Gebauer

Fátima Gebauer

  • She obtained her PhD in Sciences from the Autónoma University of Madrid, and performed postdocs in the labs of Joel Richter (UMass, USA) and Matthias Hentze (EMBL, Germany).
  • Her main interests focus on molecular mechanisms of translational control.
  • In 2002, she obtained a Group Leader position at the CRG, where her group is analyzing the role of RNA binding proteins in mRNA translation and cancer, with a focus on melanoma.
  • She is coordinator of the CRG Graduate Program, member of the Board of Directors of the UPF Doctorate School, editor of RNA and EMBO member.
  • She participates in multiple international review panels.
The project

Neurodegenerative disorders are common diseases that affect our society. They are characterized by the loss of neurons within the brain and/or spinal cord, which results in a progressive deterioration of the function of the central and peripheral nervous system.